Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
Boussier J; Yatim N; Marchal A; Hadjadj J; Charbit B; El Sissy C; Carlier N; Pène F; Mouthon L; Tharaux PL; Bergeron A; Smadja DM; Rieux-Laucat F; Duffy D; Kernéis S; Frémeaux-Bacchi V; Terrier B.
J Allergy Clin Immunol
(Unknown)
Published: 2021
Treatment of chronic or relapsing COVID-19 in immunodeficiency.
Brown LK; Moran E; Goodman A; Baxendale H; Bermingham W; Buckland M; AbdulKhaliq I; Jarvis H; Hunter M; Karanam S; Patel A; Jenkins M; Robbins A; Khan S; Simpson T; Jolles S; Underwood J; Savic S; Richter A; Shields A; Brown M; Lowe DM.
J Allergy Clin Immunol
(Unknown)
Published: 2021
SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults.
Björkander S; Du L; Zuo F; Ekström S; Wang Y; Wan H; Sherina N; Schoutens L; Andréll J; Andersson N; Georgelis A; Bergström A; Marcotte H; Kull I; Hammarström L; Melén E; Pan-Hammarström Q; BAMSE COVID-19 study group.
J Allergy Clin Immunol
(Unknown)
Published: 2021
Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure …
Delmonte OM; Castagnoli R; Yu J; Dvorak CC; Cowan MJ; Dávila Saldaña BJ; De Ravin SS; Mamcarz E; Chang CK; Daley SR; Griffith LM; Notarangelo LD; Puck JM.
J Allergy Clin Immunol
(Unknown)
Published: 2021
Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C).
Chou J; Platt CD; Habiballah S; Nguyen AA; Elkins M; Weeks S; Peters Z; Day-Lewis M; Novak T; Armant M; Williams L; Rockowitz S; Sliz P; Williams DA; Randolph AG; Geha RS; Taking on COVID-19 Together Study Investigators.
J Allergy Clin Immunol
(Unknown)
Published: 2021
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
J Allergy Clin Immunol
(Unknown)
Published: 2021
Using data from food challenges to inform management of consumers with food allergy: A systematic review with individua…
Patel N; Adelman DC; Anagnostou K; Baumert JL; Blom WM; Campbell DE; Chinthrajah RS; Mills ENC; Javed B; Purington N; Remington BC; Sampson HA; Smith AD; Yarham RAR; Turner PJ.
J Allergy Clin Immunol
(Unknown)
Published: 2021
NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
Moecking J; Laohamonthonkul P; Chalker K; White MJ; Harapas CR; Yu CH; Davidson S; Hrovat-Schaale K; Hu D; Eng C; Huntsman S; Calleja DJ; Horvat JC; Hansbro PM; O'Donoghue RJJ; Ting JP; Burchard EG; Geyer M; Gerlic M; Masters SL.
J Allergy Clin Immunol
(Unknown)
Published: 2020
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.
Finney LJ; Glanville N; Farne H; Aniscenko J; Fenwick P; Kemp SV; Trujillo-Torralbo MB; Loo SL; Calderazzo MA; Wedzicha JA; Mallia P; Bartlett NW; Johnston SL; Singanayagam A.
J Allergy Clin Immunol
(Unknown)
Published: 2020
Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort.
Nicoletti P; Carr DF; Barrett S; McEvoy L; Friedmann PS; Shear NH; Nelson MR; Chiriac AM; Blanca-López N; Cornejo-García JA; Gaeta F; Nakonechna A; Torres MJ; Caruso C; Valluzzi RL; Floratos A; Shen Y; Pavlos RK; Phillips EJ; Demoly P; Romano A; Blanca M; Pirmohamed M.
J Allergy Clin Immunol
(Unknown)
Published: 2020
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study.
Galván-Román JM; Rodríguez-García SC; Roy-Vallejo E; Marcos-Jiménez A; Sánchez-Alonso S; Fernández-Díaz C; Alcaraz-Serna A; Mateu-Albero T; Rodríguez-Cortes P; Sánchez-Cerrillo I; Esparcia L; Martínez-Fleta P; López-Sanz C; Gabrie L; Del Campo Guerola L; Suárez-Fernández C; Ancochea J; Canabal A; Albert P; Rodríguez-Serrano DA; Aguilar JM; Del Arco C; de Los Santos I; García-Fraile L; de la Cámara R; Serra JM; Ramírez E; Alonso T; Landete P; Soriano JB; Martín-Gayo E; Fraile Torres A; Zurita Cruz ND; García-Vicuña R; Cardeñoso L; Sánchez-Madrid F; Alfranca A; Muñoz-Calleja C; González-Álvaro I; REINMUN-COVID Group.
J Allergy Clin Immunol
(Unknown)
Published: 2020
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.
Abraham RS; Marshall JM; Kuehn HS; Rueda CM; Gibbs A; Guider W; Stewart C; Rosenzweig SD; Wang H; Jean S; Peeples M; King T; Hunt WG; Honegger JR; Ramilo O; Mustillo PJ; Mejias A; Ardura MI; Shimamura M.
J Allergy Clin Immunol
(Unknown)
Published: 2020
Elevated plasma sTIM-3 levels in patients with severe COVID-19.
Ueland T; Heggelund L; Lind A; Holten AR; Tonby K; Michelsen AE; Jenum S; Jørgensen MJ; Barratt-Due A; Skeie LG; Nordøy I; Aanensen Fraz MS; Quist-Paulsen E E; Pischke SE; Johal SK; Hesstvedt L; Bogen M; Fevang B; Halvorsen B; Müller F; Bekken GK; Mollnes TE; Dudman S; Aukrust P; Dyrhol-Riise AM; Holter JC.
J Allergy Clin Immunol
(Unknown)
Published: 2020
ARGX-117, a therapeutic complement inhibiting antibody targeting C2.
Van de Walle I; Silence K; Budding K; Van de Ven L; Dijkxhoorn K; de Zeeuw E; Yildiz C; Gabriels S; Percier JM; Wildemann J; Meeldijk J; Simons PJ; Boon L; Cox L; Holgate R; Urbanus R; Otten HG; Leusen JHW; Blanchetot C; de Haard H; Hack CE; Boross P.
J Allergy Clin Immunol
(Unknown)
Published: 2020